Figure 2From: Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA studyAnalysis by treatment arm of the relationship between biomarkers and pathologic complete response (pCR), adjusted for estrogen receptor status and breast cancer type (operable, locally advanced or inflammatory breast cancer). Forest plots represent the pCR rate (circle) with 95% confidence limits (line). The high or low categorization indicates whether biomarker levels were above or below the median cut point. cen, centromere; CR, concentration ratio; cyt, cytoplasmic; mem, membrane; nuc, nuclear.Back to article page